AGL (agilon health, inc.) Stock Analysis - Analyst Ratings

agilon health, inc. (AGL) is a publicly traded Healthcare sector company. As of May 21, 2026, AGL trades at $80.01 with a market cap of $1.45B and a P/E ratio of 0.00. AGL moved -8.59% today. Year to date, AGL is +367.52%; over the trailing twelve months it is +30.55%. Its 52-week range spans $7.48 to $152.00. Analyst consensus is neutral with an average price target of $37.46. Rallies surfaces AGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate AGL?

15 analysts cover AGL: 0 strong buy, 4 buy, 8 hold, 3 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $37.46.

AGL Key Metrics

Key financial metrics for AGL
MetricValue
Price$80.01
Market Cap$1.45B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.11%
52-Week High$152.00
52-Week Low$7.48
Volume28
Avg Volume0
Revenue (TTM)$5.82B
Net Income$-354.54M
Gross Margin0.00%

AGL Analyst Consensus

15 analysts cover AGL: 0 strong buy, 4 buy, 8 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $37.46.

Latest AGL News

Recent AGL Insider Trades

  • Shaker Benjamin bought 500.00K (~$301.05K) on Mar 2, 2026.
  • Wulf John William bought 81.00K (~$50.94K) on Nov 12, 2025.
  • McLoughlin Karen bought 25.00K (~$55.08K) on Dec 13, 2024.

Common questions about AGL

What do analysts rate AGL?
15 analysts cover AGL: 0 strong buy, 4 buy, 8 hold, 3 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $37.46.
Does Rallies show AGL price targets?
Yes. Rallies tracks AGL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is AGL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AGL. It does not provide personalized investment advice.
AGL

AGL